| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |